Tweenvest Stocks

Amoy Diagnostics Co., Ltd. (SZSE: 300685)

Health Care · Biotechnology · CN

CN¥18.99

-2.76% today · -23.5% 1Y

Amoy Diagnostics Co., Ltd. (SZSE: 300685) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.09B and employs 1,175 people.

Over the last twelve months the share price has lost 23.5%, trading between 15.62 and 26.15.

Tweenvest scores Amoy Diagnostics Co., Ltd. across four factors: quality 80/100, value 71/100, growth 77/100, dividend 20/100. Its strongest factor is quality.

300685 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.09B
Revenue (TTM)
$171.95M
P/E
21.33
EPS
0.89
Dividend yield
2.37%
Beta (5Y)
0.30
52-week high
CN¥26.15
52-week low
CN¥15.62
Avg volume (3M)
Shares outstanding
385.74M
Employees
1,175
Next earnings

About Amoy Diagnostics Co., Ltd.

Amoy Diagnostics Co., Ltd. is a diagnostics company focused on molecular diagnostic solutions for precision oncology. Operating both within China and across international markets, the firm provides a range of sophisticated assays, including Next-Generation Sequencing (NGS), real-time PCR, Fluorescence In Situ Hybridization (FISH), and various extraction methods. Established in 2008, Amoy Diagnostics has its base in Xiamen, China.

ISIN
CNE1000034D3
Founded
2008
Listed since
Aug 3, 2017
Exchange
Shenzhen Stock Exchange
Currency
CNY
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$468.22B$263.50-0.55%
Amgen Inc.NasdaqGS: AMGN$237.52B$440.25+0.21%
Gilead Sciences, Inc.NasdaqGS: GILD$181.18B$145.32-0.55%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.91B$548.33+0.05%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.28B$825.06-1.08%
argenx SEENXTBR: ARGX$65.85B867.40-3.84%
Moderna, Inc.NasdaqGS: MRNA$57.92B$135.44-6.64%
CSL LimitedASX: CSL$57.77BAU$168.30-1.69%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.